Target intelligence / Profile preview

Klebsiella pneumoniae Capsular Polysaccharide (Serotype K1) (K1 CPS)

Target
K1 CPS
Molecular classification
Polysaccharide, Capsular Polysaccharide, Bacterial virulence factor
01

Overview

The capsular polysaccharide (CPS) of *Klebsiella pneumoniae* serotype K1 is a high-molecular-weight, extracellular carbohydrate structure that forms the outermost layer of the bacterium. It is a major virulence factor, providing protection against host immune responses and contributing to the pathogen’s ability to cause severe infections, including pyogenic liver abscesses and invasive diseases. The K1 CPS consists of repeating trisaccharide units with unique features including extensive pyruvation of glucuronic acid, acetylation of fucose, and the presence of a fucose subunit. It functions primarily by blocking recognition by host immune receptors on phagocytes, enabling the bacteria to evade phagocytosis and clearance. Serotype K1 is among the most virulent types. Therapies targeting CPS are under investigation.

Other names
K. pneumoniae K1 capsular polysaccharideK1 serotype capsuleKlebsiella K1 CPS
02

Mechanism of action

N/A

03

Biological functions

Immune evasionBacterial virulenceProtection against phagocytosisAdhesion
04

Disease associations

InfectionPneumoniaLiver abscessSepticemia
05

Safety considerations

Potential for off-target effects if targeting conserved polysaccharide structures.Development of resistance through altered capsule structures.

Beyond the preview

Go deeper on Klebsiella pneumoniae Capsular Polysaccharide (Serotype K1) (K1 CPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Klebsiella pneumoniae Capsular Polysaccharide (Serotype K1) (K1 CPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call